The ACT Dual BPH laser device is designed for minimally invasive endoscopic operations of the urinary organs. Our proposed method is characterized by high precision, high speed of exposure, good haemostasis and low painfulness.
This allows operations on the external and internal urogenital organs on an outpatient basis, in a day patient facility or when a patient is hospitalized for a short period. This reduces the recurrence expectancy, the post-operative period is better and faster.
Indications for use:
In the prostate area:
benign prostatic hyperplasia
resection of carcinoma
lining bladder cancer
resection of lymph nodes
condylomata acuminata (genital warts)
urethral and ureteral stenoses
Order a commercial offer
Increased laser power and the summation of two wavelengths allow the treatment of benign prostatic hyperplasia. Contact laser ablation at 60W radiation power makes it possible to achieve the removal of small-sized lobes of prostate gland in BPH. At 100W power and more, the volumetric evaporation occurs – the ablation of adenomatous tissue, which is important for the larger lobes of the adenoma.
There are various options for using the ACT Dual BPH diode laser for prostate diseases:
Incision of the bladder neck in prostate sclerosis.
Isolated removal of the Morgagni’s caruncle by laser ablation. It is possible to remove the lateral lobes with a small-sized hyperplasia (up to 40 cm3).
Step-by-step ablation of prostate tissue using the ‘twister fiber’. In the aquatic environment, vaporization of the tissue water occurs, and then vaporization of the parts of the tissue remaining after evaporation occurs. Contact ablation should be performed from the lateral lobes, bringing the laser fibre directly to the prostate tissue, with a subsequent transition to the Morgagni’s caruncle. When the size of the hyperplastic gland is small, laser ablation occurs directly up to the prostatic capsule.